Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FITWISE
NCT06518837Phase 2Recruiting
- Sponsor
- Rutgers University
- Start
- Oct 2024
- Primary completion
- Sep 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in obesity, sponsored by Rutgers University. Started Oct 2024; status: recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06518837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06518837.